Physician profile
Nathan Yu
NPI 1679036040
$3,371.82
in general payments reported to CMS, 2019-2025
10 companies · $352 in 2025
The $352 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2024: $2,778 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.88 |
| Travel and Lodging | $995.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,790.02 | 2021-2025 | Vercise, Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $693.94 | 2024 | Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $324.31 | 2024-2025 | Prospera |
| Saluda Medical Americas, INC. | $202.56 | 2024 | Evoke |
| Stratus Medical, LLC | $143.38 | 2025 | Nimbus |
| Abbott Laboratories | $80.36 | 2024 | Eterna |
| Pacira Pharmaceuticals Incorporated | $47.33 | 2024 | Exparel, Zilretta |
| Abbvie INC. | $34.60 | 2024 | |
| Mml US, INC. | $31.21 | 2025 | Reactiv8 |
| Avanos Medical | $24.11 | 2024 | Coolief* Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.